中科干细胞的相关学术翻译3

中科基本情况INTRODUCTION
 
   吉林省中科生物工程有限公司是以生物工程技术为主的科技型企业，致力于干细胞产品与技术在再生治疗中的应用。公司总资产4178万元人民币，占地25000平方米，建筑面积3780平方米，已按工业化标准完成全部配套工程。配有国际化现代化高尖端研究、科研、生产设备。研发团队拥有专业技术人员44人，均具有生物工程、生物制剂专业特长，其中34人拥有生物工程及生物化学等专业硕士、博士学位。
 
   Jilin Zhongke Bio-engineering Co., Ltd. (JZB) is a leader in bio-engineering research. JZB focuses on applications of stem cells related products and technologies in regenerative therapy. With a total investment of 41.78 million RMB, it has established 3780 m2 research and production facility according to industry standards. It has 44 technicists (34 with Master Degree or Ph.D. degrees in stem cells or tissue engineering) in research.
 
 

    干细胞、组织工程、再生医疗是公司的特色项目。近年来，应用干细胞对恶性肿瘤和糖尿病的治疗取得了重大的突破。并成为国家卫生部首次正式批准干细胞技术在临床应用的单位。
 
   JZB focuses on stem cell research, tissue engineering and regenerative therapy.Thus far,JZB has made major advancements in treating cancer and diabetes using stem cell technologies. JZB got the first license from Ministry of Health of the P.R.China to carry on the stem cell technology in clinical application.